Early trials using anti-CD19 CAR T cells have shown promising results in treating conditions like SLE (systemic lupus erythematosus) and other autoimmune disorders (5, 10, 12, 22, 23). The gene discussed is CD19; the disease is systemic lupus erythematosus.